Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

8 Dec 2016 07:00

RNS Number : 2463R
MJ Gleeson PLC
08 December 2016
 

MJ Gleeson PLC

(GLE.L)

 

AGM Statement

 

At the Annual General Meeting of MJ Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, convened for 11:30 am today in London, the Chairman, Dermot Gleeson, will state:

"Demand has been strong at Gleeson Homes with net reservations up 20%.

"Site activity is high with 14 new sites opened during the last six months. The division currently has 50 active sites, compared with 44 at this time last year and we expect the number to exceed 50 by June 2017.

"Demand remains strong with several of our new sites attracting lengthy queues before opening.

"The Government's Help to Buy scheme remained popular during the period, with 65% of customers taking advantage of it, while others continue to be attracted by our own bespoke purchaser assistance packages.

"A new regional office will open in Nottingham soon, increasing the division's operational reach in the North Midlands and taking the total number of regional offices to seven.

"Gleeson Homes currently has a land pipeline of 9,310 plots, of which 4,667 are owned and 4,643 are conditionally purchased, along with a further 1,667 plots under active consideration.

"The division's increasing number of sales outlets, combined with very strong customer demand in all regions, good mortgage availability and attractive levels of affordability means that the outlook for the division is very positive.

"The Board expects Gleeson Homes to record an increase in completions for the first half year to 31 December 2016 of more than 10% compared with the prior half year total of 400 units; and for the year to 30 June 2017 of approximately 15% compared with the prior year total of 904 units.

"In the first five months of the current financial year, Gleeson Strategic Land continued to experience strong demand for consented land, completing the sale of two sites with planning permission for a combined total of 180 consented plots and progressing sale negotiations on a further 11 sites.

"The division's land pipeline currently consists of 67 sites which have the potential to deliver approximately 21,341 plots. The portfolio includes 14 sites with planning permission.

"We expect Gleeson Strategic Land results for the full year June 2017 to be broadly in line with results for the prior financial year, with the second half being significantly stronger than the first half.

"Whilst the timing of sales in the Strategic Land division means that the Group results for the first six months of the financial year will be slightly below the first half of the prior year, the Board remains confident that the result for the full year to 30 June 2017 will be in line with expectations."

 

8 December 2016

 

Enquiries:

MJ Gleeson plc

 

Tel: +44 1142 612 900

Jolyon Harrison

Chief Executive Officer

 

Stefan Allanson

Chief Financial Officer

 

 

 

 

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

 

Helen Tarbet

James Gray

 

 

 

N+1 Singer

 

Shaun Dobson

Tel: +44 20 7496 3000

Alex Laughton-Scott

 

 

 

Liberum

 

Neil Patel

Tel: +44 20 3100 2111

Richard Bootle

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFMMGZVNNGVZM
Date   Source Headline
25th Mar 20204:35 pmRNSPrice Monitoring Extension
25th Mar 20203:38 pmRNSCovid-19 Update
23rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202012:08 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
9th Mar 20209:49 amRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSTotal Voting Rights
13th Feb 202012:02 pmRNSPrice Monitoring Extension
13th Feb 20207:00 amRNSHalf-year Report
10th Feb 20202:32 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSTotal Voting Rights
9th Jan 20207:00 amRNSNotice of Results and Trading Update
8th Jan 20206:05 pmRNSDirector/PDMR Shareholding
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20196:09 pmRNSExercise of options, PDMR Dealing and TVR
19th Dec 201912:07 pmRNSSecond Price Monitoring Extn
19th Dec 201912:02 pmRNSPrice Monitoring Extension
18th Dec 201910:15 amRNSDirector/PDMR Shareholding
11th Dec 20195:22 pmRNSPerformance Share Plan award to Directors/PDMRs
9th Dec 201911:31 amRNSDirector/PDMR Shareholding
5th Dec 20193:18 pmRNSResult of AGM
5th Dec 20197:00 amRNSAGM Statement
3rd Dec 20194:07 pmRNSTotal Voting Rights
2nd Dec 20197:01 amRNSIncentive Plan Share Issue
2nd Dec 20197:00 amRNSAppointment of Chief Executive Officer
29th Nov 20197:00 amRNSTotal Voting Rights
12th Nov 20193:40 pmRNSPerformance Share Plan award to Directors/PDMRs
11th Nov 201910:12 amRNSDirector/PDMR Shareholding
4th Nov 20197:00 amRNSNotice of AGM
31st Oct 201912:13 pmRNSRe Committee Appointments
31st Oct 20197:00 amRNSTotal Voting Rights
16th Oct 20193:58 pmRNSHolding(s) in Company
9th Oct 201912:05 pmRNSDirector/PDMR Shareholding
9th Oct 201911:46 amRNSDirector/PDMR Shareholding
8th Oct 20192:09 pmRNSExercise of Options and Total Voting Rights
30th Sep 20197:00 amRNSTotal Voting Rights
24th Sep 20197:00 amRNSAppointment of Non-Executive Directors
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
16th Sep 20197:00 amRNSFinal Results
10th Sep 20195:35 pmRNSDirector/PDMR Shareholding
30th Aug 20197:00 amRNSTotal Voting Rights
14th Aug 20194:35 pmRNSPrice Monitoring Extension
8th Aug 20199:32 amRNSDirector/PDMR Shareholding
7th Aug 20191:40 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 201910:55 amRNSDirector/PDMR Shareholding
4th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSTotal Voting Rights
10th Jun 20192:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.